RecruitingNCT02061787
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
Sponsor
Chinese Pulmonary Vascular Disease Research Group
Enrollment
4,000 participants
Start Date
Sep 1, 2010
Study Type
OBSERVATIONAL
Conditions
Summary
cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment
Eligibility
Min Age: 5 YearsMax Age: 100 Years
Inclusion Criteria3
- pulmonary arterial hypertension;( WHO1)
- chronic thromboembolic pulmonary hypertension;
- pulmonary arterial hypertension due to other cause;
Exclusion Criteria5
- massive hemoptysis;
- unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders;
- recent recurrent syncope;
- pulmonary hypertension due to hypoxia;
- pulmonary hypertension due to left heart diseases.
Interventions
DEVICEballoon pulmonary angioplasty
patients with chronic thromboembolic pulmonary hypertension who underwent balloon pulmonary angioplasty
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02061787
Related Trials
Development of Novel Physiological CMR Methods in Health and Disease
NCT038540711 location
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
NCT0707382036 locations
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
NCT017300921 location
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
NCT074771971 location
Preliminary Human Trials of F230 Tablets
NCT068998151 location